Teva Pharmaceutical Industries reported $2.44B in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 79.96M 42.74M
ALKERMES ALKS:US $ 258.34M 53.31M
Amarin AMRN:US $ 327.02M 36.02M
Amgen AMGN:US $ 6630M 518M
AstraZeneca AZN:LN 15567M 7931M
Biogen BIIB:US $ 1742M 524.5M
Bristol Myers Squibb BMY:US $ 11024M 42M
Coherus Biosciences CHRS:US $ 329.74M 70.25M
Eli Lilly And LLY:US $ 3220M 217.6M
Emergent Biosolutions EBS:US $ 447.5M 100.3M
Endo International Ordinary Shares ENDP:US $ 1545.17M 117.4M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
Gilead Sciences GILD:US $ 7361M 3296M
GlaxoSmithKline GSK:LN 3503M 1254M
Henry Schein HSIC:US $ 167.23M 22.69M
Horizon Pharma HZNP:US $ 812.32M 0.71M
Lannett LCI:US $ 93.29M 12M
Novartis NOVN:VX SF 5117M 1316M
Pacira Pharmaceuticals PCRX:US $ 105.77M 39.08M
Patterson Companies PDCO:US $ 136.93M 6.31M
Perrigo Ordinary Shares PRGO:US $ 317.5M 153.4M
Phibro Animal Health PAHC:US $ 50.21M 1.11M
Revance Therapeutics RVNC:US $ 167.63M 81.79M
Supernus Pharmaceuticals SUPN:US $ 223.77M 31.87M
Takeda 4502:JP Y 654920M 311302M
Teva Pharmaceutical Industries TEVA:US $ 2436M 693M
Xeris Pharmaceuticals Inc XERS:US $ 63.6M 3M
Zoetis ZTS:US $ 3657M 57M